These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 22202200)
41. Synthesis and antitumor activity of 3-(2-phenyl-1,3-thiazol-4-yl)-1H-indoles and 3-(2-phenyl-1,3-thiazol-4-yl)-1H-7-azaindoles. Diana P; Carbone A; Barraja P; Montalbano A; Parrino B; Lopergolo A; Pennati M; Zaffaroni N; Cirrincione G ChemMedChem; 2011 Jul; 6(7):1300-9. PubMed ID: 21523912 [TBL] [Abstract][Full Text] [Related]
42. Synthesis of new 2-(5-substituted-3-phenyl-2-pyrazolinyl)-1,3-thiazolino[5,4-b]quinoxaline derivatives and evaluation of their antiamoebic activity. Budakoti A; Bhat AR; Azam A Eur J Med Chem; 2009 Mar; 44(3):1317-25. PubMed ID: 18378360 [TBL] [Abstract][Full Text] [Related]
44. Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity. Loriga M; Moro P; Sanna P; Paglietti G; Zanetti S Farmaco; 1997; 52(8-9):531-7. PubMed ID: 9507661 [TBL] [Abstract][Full Text] [Related]
45. Synthesis and acrosin inhibitory activity of substituted 4-amino-N-(diaminomethylene) benzenesulfonamide derivatives. Ding L; Zhu J; Zheng C; Sheng C; Qi J; Liu X; Han G; Zhao J; Lv J; Zhou Y Bioorg Med Chem Lett; 2011 Nov; 21(22):6674-7. PubMed ID: 21983437 [TBL] [Abstract][Full Text] [Related]
46. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma. Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757 [TBL] [Abstract][Full Text] [Related]
47. Synthesis of N-(5,7-diamino-3-phenyl-quinoxalin-2-yl)-3,4,5-substituted anilines and N-[4[(5,7-diamino-3-phenylquinoxalin-2-yl)amino]benzoyl]-l-glutamic acid diethyl ester: evaluation of in vitro anti-cancer and anti-folate activities. Corona P; Loriga M; Costi MP; Ferrari S; Paglietti G Eur J Med Chem; 2008 Jan; 43(1):189-203. PubMed ID: 17532099 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems. Rostom SA Bioorg Med Chem; 2006 Oct; 14(19):6475-85. PubMed ID: 16806944 [TBL] [Abstract][Full Text] [Related]
49. Quinoxaline chemistry. Part XVII. Methyl [4-(substituted 2-quinoxalinyloxy) phenyl] acetates and ethyl N-([4-(substituted 2-quinoxalinyloxy) phenyl] acetyl) glutamates analogs of methotrexate: synthesis and evaluation of in vitro anticancer activity. Piras S; Loriga M; Paglietti G Farmaco; 2004 Mar; 59(3):185-94. PubMed ID: 14987981 [TBL] [Abstract][Full Text] [Related]
50. Dual-acting agents that possess reversing resistance and anticancer activities: Design, synthesis, MES-SA/Dx5 cell assay, and SAR of Benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3',4':1,2]pyridin[3,4-b]indol-2-substitutedacetates. Liu J; Cui G; Zhao M; Cui C; Ju J; Peng S Bioorg Med Chem; 2007 Dec; 15(24):7773-88. PubMed ID: 17888666 [TBL] [Abstract][Full Text] [Related]
51. Design, synthesis, and biological evaluation of novel N-γ-carboline arylsulfonamides as anticancer agents. Chen J; Liu T; Wu R; Lou J; Cao J; Dong X; Yang B; He Q; Hu Y Bioorg Med Chem; 2010 Dec; 18(24):8478-84. PubMed ID: 21067933 [TBL] [Abstract][Full Text] [Related]
52. N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer. Wang YM; Hu LX; Liu ZM; You XF; Zhang SH; Qu JR; Li ZR; Li Y; Kong WJ; He HW; Shao RG; Zhang LR; Peng ZG; Boykin DW; Jiang JD Clin Cancer Res; 2008 Oct; 14(19):6218-27. PubMed ID: 18829501 [TBL] [Abstract][Full Text] [Related]
53. Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives. Moorthy NS; Karthikeyan C; Trivedi P J Enzyme Inhib Med Chem; 2010 Jun; 25(3):394-405. PubMed ID: 20233012 [TBL] [Abstract][Full Text] [Related]
54. Quinoxaline derivatives. Part II: Synthesis and antimicrobial testing of 1,2,4-triazolo[4,3-a]quinoxalines, 1,2,4-triazino[4,3-a]quinoxalines and 2-pyrazolylquinoxalines. el-Hawash SA; Habib NS; Fanaki NH Pharmazie; 1999 Nov; 54(11):808-13. PubMed ID: 10603606 [TBL] [Abstract][Full Text] [Related]
55. 2-Mercapto-N-(azolyl)benzenesulphonamides. I. Synthesis of N-(1,1-dioxo-1,4,2-benzodithiazin-3-yl)guanidines and their transformations into 2-mercapto-N-(5-amino-1,2,4-triazol-3-yl) benzenesulphonamide derivatives with potential anti-HIV or anticancer activity. Brzozowski Z Acta Pol Pharm; 1995; 52(2):91-101. PubMed ID: 8960241 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity. Xie F; Zhao H; Zhao L; Lou L; Hu Y Bioorg Med Chem Lett; 2009 Jan; 19(1):275-8. PubMed ID: 19028425 [TBL] [Abstract][Full Text] [Related]
57. Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase. Röver S; Cesura AM; Huguenin P; Kettler R; Szente A J Med Chem; 1997 Dec; 40(26):4378-85. PubMed ID: 9435907 [TBL] [Abstract][Full Text] [Related]
58. Synthesis and biological evaluation of some novel fused pyrazolopyrimidines as potential anticancer and antimicrobial agents. Abd El Razik HA; Wahab AE Arch Pharm (Weinheim); 2011 Mar; 344(3):184-96. PubMed ID: 21384418 [TBL] [Abstract][Full Text] [Related]
59. Synthesis of some novel quinolines and pyrimido [4,5-b] quinolines bearing A sulfonamide moiety as potential anticancer and radioprotective agents. Ghorab MM; Ragab FA; Noaman E; Heiba HI; El-Hossary EM Arzneimittelforschung; 2007; 57(12):795-803. PubMed ID: 18380413 [TBL] [Abstract][Full Text] [Related]
60. Novel thiophenes, thienopyrimidines, and triazolothienopyrimidines for the evaluation of anticancer and augmentation effects of gamma-radiation. Shaaban MA; Ghorab MM; Heiba HI; Kamel MM; Zaher NH; Mostafa MI Arch Pharm (Weinheim); 2010 Jul; 343(7):404-10. PubMed ID: 20379969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]